Enfusion Inc.

NYS: ENFN

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Enfusion Inc.

Market open

--Real time quotes

Mar 24, 2023, 2:56 p.m.

ENFN

/zigman2/quotes/230006699/composite

10.37

Change

-0.09 -0.86%

Volume

Volume 95,895

Real time quotes

/zigman2/quotes/230006699/composite

Previous close

$ 10.46

$ 10.37

Change

-0.09 -0.86%

Day low

Day high

$10.28

$10.47

52 week low

52 week high

$7.80

$16.76

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Enfusion Inc.

View Ratios

Fiscal year is January-December. All values USD millions.		2019	2020	2021	2022	5-year trend
Sales/Revenue	-	59.03M	79.57M	111.7M	150.35M
Sales Growth	-	-	34.79%	40.39%	34.60%
Cost of Goods Sold (COGS) incl. D&A	-	16.96M	21.36M	31.85M	47.1M
COGS excluding D&A	-	15.8M	19.07M	27.87M	40.5M
Depreciation & Amortization Expense	-	1.16M	2.29M	3.98M	6.6M
Depreciation	-	1.16M	2.29M	3.98M	6.6M
Amortization of Intangibles	-	-	-	-	-
COGS Growth	-	-	25.92%	49.10%	47.90%
Gross Income	-	42.07M	58.21M	79.86M	103.25M
Gross Income Growth	-	-	38.37%	37.19%	29.30%
Gross Profit Margin	-	-	-	-	68.67%	NA

		2019	2020	2021	2022	5-year trend
SG&A Expense	-	28.2M	52.13M	355.74M	115.21M
Research & Development	-	4.15M	6.32M	153.4M	17.16M
Other SG&A	-	24.05M	45.82M	202.34M	98.05M
SGA Growth	-	-	84.89%	582.37%	-67.61%
Other Operating Expense	-	-	-	-	-
Unusual Expense	-	-	-	1.22M	-
EBIT after Unusual Expense	-	-	-	(277.1M)	-
Non Operating Income/Expense	-	(3,000)	82,000	30,000	(638,000)
Non-Operating Interest Income	-	-	-	-	413,000
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	-	724,000	1.66M	4.59M	-
Interest Expense Growth	-	-	129.56%	176.41%	-
Gross Interest Expense	-	724,000	1.66M	4.59M	-
Interest Capitalized	-	-	-	-	-
Pretax Income	-	13.14M	4.49M	(281.66M)	(12.19M)
Pretax Income Growth	-	-	-65.80%	-6,367.53%	95.67%
Pretax Margin	-	-	-	-	-8.11%	NA
Income Tax	-	486,000	433,000	579,000	1.07M
Income Tax - Current Domestic	-	-	-	-	-
Income Tax - Current Foreign	-	-	-	228,000	1.35M
Income Tax - Deferred Domestic	-	-	-	-	-
Income Tax - Deferred Foreign	-	-	-	351,000	(273,000)
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	-	12.66M	4.06M	(282.24M)	(13.26M)
Minority Interest Expense	-	-	-	(123.93M)	(5.61M)
Net Income	-	12.66M	4.06M	(158.32M)	(7.65M)
Net Income Growth	-	-	-67.91%	-3,998.47%	95.17%
Net Margin Growth	-	-	-	-	-5.09%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	-	12.66M	4.06M	(158.32M)	(7.65M)
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	-	12.66M	4.06M	(158.32M)	(7.65M)
EPS (Basic)	-	0.11	0.04	(2.41)	(0.09)
EPS (Basic) Growth	-	-	-67.95%	-6,824.23%	96.29%
Basic Shares Outstanding	-	113.05M	113.05M	65.58M	85.39M
EPS (Diluted)	-	0.11	0.04	(2.41)	(0.09)
EPS (Diluted) Growth	-	-	-67.95%	-6,824.23%	96.29%
Diluted Shares Outstanding	-	113.05M	113.05M	65.58M	85.39M
EBITDA	-	15.03M	8.37M	(271.91M)	(5.36M)
EBITDA Growth	-	-	-44.33%	-3,350.56%	98.03%
EBITDA Margin	-	-	-	-	-3.57%	NA

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Enfusion Inc.

Annual Financials for Enfusion Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk